Your browser doesn't support javascript.
loading
Therapy-related acute myeloid leukemia developing 14 years after allogeneic hematopoietic stem cell transplantation, from a persistent R882H-DNMT3A mutated clone of patient origin.
Martín, Iván; Navarro, Blanca; Villamón, Eva; Solano, Carlos; Serrano, Alicia; Calabuig, Marisa; Amat, Paula; Domingo, Fernando; Abellán, Rosario; García, Francisca; Olivares, María Dolores; Chaves, Francisco Javier; Tormo, Mar; Hernández-Boluda, Juan Carlos.
  • Martín I; Hematology Department, Hospital Clínico Universitario, INCLIVA Research Institute, University of Valencia, Valencia, Spain. Electronic address: marcasi@alumni.uv.es.
  • Navarro B; Hematology Department, Hospital Clínico Universitario, INCLIVA Research Institute, University of Valencia, Valencia, Spain. Electronic address: nacublan@ext.uv.es.
  • Villamón E; Hematology Department, Hospital Clínico Universitario, INCLIVA Research Institute, University of Valencia, Valencia, Spain. Electronic address: eva.villamon@uv.es.
  • Solano C; Hematology Department, Hospital Clínico Universitario, INCLIVA Research Institute, University of Valencia, Valencia, Spain; Department of Medicine, School of Medicine, University of Valencia, Valencia, Spain. Electronic address: carlos.solano@uv.es.
  • Serrano A; Hematology Department, Hospital Clínico Universitario, INCLIVA Research Institute, University of Valencia, Valencia, Spain.
  • Calabuig M; Hematology Department, Hospital Clínico Universitario, INCLIVA Research Institute, University of Valencia, Valencia, Spain.
  • Amat P; Hematology Department, Hospital Clínico Universitario, INCLIVA Research Institute, University of Valencia, Valencia, Spain.
  • Domingo F; Hematology Department, Hospital Clínico Universitario, INCLIVA Research Institute, University of Valencia, Valencia, Spain.
  • Abellán R; Genomic and Genotyping Unit, INCLIVA Research Institute, University of Valencia, Valencia, Spain. Electronic address: m.rosario.abellan@uv.es.
  • García F; Hematology Department, Hospital Clínico Universitario, INCLIVA Research Institute, University of Valencia, Valencia, Spain.
  • Olivares MD; Genomic and Genotyping Unit, INCLIVA Research Institute, University of Valencia, Valencia, Spain.
  • Chaves FJ; Genomic and Genotyping Unit, INCLIVA Research Institute, University of Valencia, Valencia, Spain. Electronic address: felipe.chaves@uv.es.
  • Tormo M; Hematology Department, Hospital Clínico Universitario, INCLIVA Research Institute, University of Valencia, Valencia, Spain. Electronic address: tormo_mar@gva.es.
  • Hernández-Boluda JC; Hematology Department, Hospital Clínico Universitario, INCLIVA Research Institute, University of Valencia, Valencia, Spain. Electronic address: hernandez_jca@gva.es.
Exp Mol Pathol ; 105(1): 139-143, 2018 08.
Article en En | MEDLINE | ID: mdl-30017658
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Médula Ósea / Mutación Missense / ADN (Citosina-5-)-Metiltransferasas Límite: Adult / Humans / Male Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Médula Ósea / Mutación Missense / ADN (Citosina-5-)-Metiltransferasas Límite: Adult / Humans / Male Idioma: En Año: 2018 Tipo del documento: Article